SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Israel’s Septier sold Mexico a cellphone surveillance system. Then it repeatedly failed.

Israel’s Iron Beam laser was hailed as a breakthrough. It still isn’t operational

Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling

SuperPlay may be worth more than Playtika itself as gaming firm's market value hits record low

Buzz

Most popular

Daily

Weekly

1

Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling

2

Israel set to reject $4.2 billion Zim sale despite buyers’ concessions

3

Israel’s Iron Beam laser was hailed as a breakthrough. It still isn’t operational

4

Talkspace co-founder Oren Frank dies at 60 after battle with cancer

5

Intel’s frozen $283 million grant is headed to Israel’s defense budget

PhaseV

4 stories about PhaseV

Promising HealthTech

WATCH: CTech's most promising healthtech startups

Here's everything you need to know about Sensi.ai, Briya Labs, PhaseV, Zorro, and DeepCure

כנס ניו יורק - ד"ר רביב פרילוק מנכ"ל PhaseV

PhaseV raises $50 million Series A to rethink how drugs get to market

With over 30 global customers, the AI startup targets inefficiencies in clinical trials.

CTech NY Conference Dr Raviv Pryluk

Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development

27.03.25|James Spiro

CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalist’s Mind The Tech conference in New York.

Raviv Pryluk PhaseV

PhaseV raises $15 million to optimize clinical trials with causal machine learning

The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps